» Authors » German Soriano

German Soriano

Explore the profile of German Soriano including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 101
Citations 2861
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pose E, Jimenez C, Zaccherini G, Campion D, Piano S, Uschner F, et al.
JAMA . 2025 Feb; 333(10):864-874. PMID: 39908052
Importance: There are no useful treatments to prevent the development of severe complications of liver cirrhosis. Simvastatin and rifaximin have shown beneficial effects in liver cirrhosis. Objective: To assess whether...
2.
Diaz-Ruiz R, Poca M, Roman E, Panadero-Gomez R, Cuyas B, Banares I, et al.
Nutrients . 2025 Jan; 17(2. PMID: 39861356
Decompensated cirrhosis is characterized by systemic inflammation and innate and adaptive immune dysfunction. Hepatic encephalopathy (HE) is a prevalent and debilitating condition characterized by cognitive disturbances in which ammonia and...
3.
Laghi L, Ortiz M, Rossi G, Roman E, Mengucci C, Canto E, et al.
Biomolecules . 2024 Nov; 14(11). PMID: 39595586
Frailty in cirrhosis or advanced chronic liver disease (ACLD) is a relevant prognostic factor. In the present study, we aimed to analyze potential biomarkers associated with frailty and its improvement...
4.
Brujats A, Huerta A, Osuna-Gomez R, Guinart-Cuadra A, Ferrero-Gregori A, Pujol C, et al.
Int J Mol Sci . 2024 Aug; 25(15). PMID: 39125872
Advanced chronic liver disease (ACLD) is associated with a wide spectrum of immune dysfunction. The clinical impact of SARS-CoV-2 on the development of decompensation and immune response in unvaccinated outpatients...
5.
Roman E, Kaur N, Sanchez E, Poca M, Padros J, Nadal M, et al.
Hepatol Commun . 2024 May; 8(5). PMID: 38701490
Background: Frailty is a predictive factor of hospitalization, falls, and mortality in patients with cirrhosis, regardless of the degree of liver failure. The aim was to analyze whether a multifactorial...
6.
Dunn W, Li Y, Singal A, Simonetto D, Diaz L, Idalsoaga F, et al.
Hepatology . 2024 Apr; 80(5):1196-1211. PMID: 38607809
Background And Aims: Alcohol-associated hepatitis (AH) poses significant short-term mortality. Existing prognostic models lack precision for 90-day mortality. Utilizing artificial intelligence in a global cohort, we sought to derive and...
7.
Cuyas B, Huerta A, Poca M, Alvarado-Tapias E, Brujats A, Roman E, et al.
Sci Rep . 2024 Feb; 14(1):2718. PMID: 38302563
Infections are a major cause of morbidity and mortality in cirrhosis, especially those caused by multi-drug resistant bacteria. During the COVID-19 pandemic, the incidence and type of infection in these...
8.
Medina-Caliz I, Sanabria-Cabrera J, Villanueva-Paz M, Aukstikalne L, Stephens C, Robles-Diaz M, et al.
Arch Toxicol . 2023 Dec; 98(1):303-325. PMID: 38051367
Idiosyncratic drug-induced liver injury (DILI) associated with drug reactions with eosinophilia and systemic symptoms (DRESS) is poorly characterized among patients of Western countries. We aimed to comprehensively assess the clinical...
9.
Juanola A, Ma A, de Wit K, Gananandan K, Roux O, Zaccherini G, et al.
Gut . 2023 Oct; 73(1):156-165. PMID: 37884354
Background: Patients with decompensated cirrhosis experience high mortality rates. Current prognostic scores, including the model for end-stage liver disease (MELD), may underperform in settings other than in those they were...
10.
Mehta G, Riva A, Ballester M, Uson E, Pujadas M, Carvalho-Gomes A, et al.
Hepatol Commun . 2023 Oct; 7(11). PMID: 37870985
Background: Vaccine hesitancy and lack of access remain major issues in disseminating COVID-19 vaccination to liver patients globally. Factors predicting poor response to vaccination and risk of breakthrough infection are...